Targeted Nanotherapeutics Using LACTB Gene Therapy Against Melanoma.
Jinlu LiuLing YangXin YuanMeimei XiongJiao ZhuWenbi WuMin RenJianlin LongXuewen XuMaling GouPublished in: International journal of nanomedicine (2021)
The downregulated LACTB might be a potential target for melanoma therapy. The iDPP/LACTB nanocomplexes could inhibit the growth of the mouse melanoma without obvious side effects, which provide a new option for melanoma gene therapy research.